Unknown

Dataset Information

0

Directed evolution of phosphite dehydrogenase to cycle noncanonical redox cofactors via universal growth selection platform.


ABSTRACT: Noncanonical redox cofactors are attractive low-cost alternatives to nicotinamide adenine dinucleotide (phosphate) (NAD(P)+) in biotransformation. However, engineering enzymes to utilize them is challenging. Here, we present a high-throughput directed evolution platform which couples cell growth to the in vivo cycling of a noncanonical cofactor, nicotinamide mononucleotide (NMN+). We achieve this by engineering the life-essential glutathione reductase in Escherichia coli to exclusively rely on the reduced NMN+ (NMNH). Using this system, we develop a phosphite dehydrogenase (PTDH) to cycle NMN+ with ~147-fold improved catalytic efficiency, which translates to an industrially viable total turnover number of ~45,000 in cell-free biotransformation without requiring high cofactor concentrations. Moreover, the PTDH variants also exhibit improved activity with another structurally deviant noncanonical cofactor, 1-benzylnicotinamide (BNA+), showcasing their broad applications. Structural modeling prediction reveals a general design principle where the mutations and the smaller, noncanonical cofactors together mimic the steric interactions of the larger, natural cofactors NAD(P)+.

SUBMITTER: Zhang L 

PROVIDER: S-EPMC9418148 | biostudies-literature | 2022 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Directed evolution of phosphite dehydrogenase to cycle noncanonical redox cofactors via universal growth selection platform.

Zhang Linyue L   King Edward E   Black William B WB   Heckmann Christian M CM   Wolder Allison A   Cui Youtian Y   Nicklen Francis F   Siegel Justin B JB   Luo Ray R   Paul Caroline E CE   Li Han H  

Nature communications 20220826 1


Noncanonical redox cofactors are attractive low-cost alternatives to nicotinamide adenine dinucleotide (phosphate) (NAD(P)<sup>+</sup>) in biotransformation. However, engineering enzymes to utilize them is challenging. Here, we present a high-throughput directed evolution platform which couples cell growth to the in vivo cycling of a noncanonical cofactor, nicotinamide mononucleotide (NMN<sup>+</sup>). We achieve this by engineering the life-essential glutathione reductase in Escherichia coli to  ...[more]

Similar Datasets

| S-EPMC9304416 | biostudies-literature
| S-EPMC5320008 | biostudies-literature
| S-EPMC7479625 | biostudies-literature
| S-EPMC8717395 | biostudies-literature
| S-EPMC9516700 | biostudies-literature
| S-EPMC4316821 | biostudies-literature
| S-EPMC5737638 | biostudies-literature
| S-EPMC7238262 | biostudies-literature
| S-EPMC3744125 | biostudies-literature
| S-EPMC8234031 | biostudies-literature